DigitalDx Ventures

🎙️ New Podcast Episode ⭐ DigitalDx Ventures Founder + Managing Partner Michele Colucci, Esq., joins Dakota CEO Gui Costin, host of the ☔ RAINMAKER podcast. to explore how AI is transforming healthcare diagnostics—and how the DigitalDx Ventures mission-driven team is leading the charge. From early detection to investment strategy, Michele shares powerful insights on innovation, leadership, and building with purpose. WATCH NOW: https://lnkd.in/exacJGeB #RainmakerPodcast #VentureCapital #HealthcareInnovation #AIinHealthcare #DigitalDxVentures #DakotaMarketplace #HealthTech #ImpactInvesting #HealthTechNews Erin Niehaus - CFP®, CEPA David Kirk Eric L. Weiss, MD

We are thrilled to announce the promotion of Karim ReFaey, M.D., M.S.E., our talented Associate, to the position of Principal at DigitalDx Ventures! DigitalDx Ventures Founder + Managing Partner Michele Colucci, Esq. said, "Starting as a DigitalDx Fellow, then Fellow Leader, then Associate, Karim has increasingly taken on key responsibilities with the Fund. His journey is really a testament to the power of combining clinical expertise with technology. As a physician-scientist with a background in neurosurgery and biomedical engineering, Karim has been able to create and apply AI tools to better enhance DigitalDx's process and outcomes on many levels, managing the Fund's ever increasing deal flow funnel. His deep understanding of the challenges and opportunities in healthcare innovation are perfectly aligned with DigitalDx's investment strategy of using the power of AI to help make doctors smarter.” Karim earned his MD in Egypt Karim earned a MSE in Biomedical Engineering from  Johns Hopkins Whiting School of Engineering.  He has held clinical and research positions at The Johns Hopkins University and the Mayo Clinic, where he focused on NeuroTech, brain tumors, epilepsy, and brain-computer interfaces. While at Mayo, he co-invented a groundbreaking medical device for intra-operative brain mapping and epilepsy monitoring, now being used to improve outcomes for patients undergoing brain surgery. His Industry experience includes working with top companies like Siemens Healthineers, Johnson & Johnson, and Abbott Core Diagnostics, working in areas ranging from clinical development to regulatory strategy to and commercialization. Congratulations Karim ReFaey, M.D., M.S.E., MD! DigitalDx Ventures is a majority women-owned Silicon Valley fund delivering outsized financial and social impact through a triple bottom line strategy: meaningful returns, access to healthcare, and gender parity. #ImpactInvesting #VentureInvesting #HealthcareInnovation  #VentureCapitalNews #VCNews #VC #HealthTechnology #HealthTech #BiomedicalEngineering  #MedTech  #Healthcare 

DigitalDx Ventures Founder + Managing Partner Michele Colucci, Esq. Colucci was honored to be included on Jeremy Daniels' 'Eleven Female Investors to Follow on LinkedIn' list which included: Lindsay Karas Stencel - Seasoned Investor & Startup & VC Attorney Law Michele Colucci, Esq. - CEO DigitalDx Ventures Maneesha Ghiya - Managing Partner & Founder of FemHealth Ventures Kristin Hull, PhD - Impact investor, building public market investment portfolios Mala Ramakrishnan - Founder and Managing Partner at Progressive Ventures Lu Zhang - Founder & Managing Partner at Fusion Fund Jessica Karr - Coyote Ventures Founder & Managing Director Aileen Lee - Early stage investor & founder at Cowboy Ventures Alison Rosenthal (She / Her) - Founder and Managing Partner at Leadout Capital Milo Werner - General Partner DCVC Deborah Magid - Co-Founder and Managing Director, DoubleStar Venture Partners MORE: https://lnkd.in/gg2KeFnn #VentureCapitalNews #VentureCapital #WomeninVenture #ImpactInvesting #VC

DigitalDx Ventures welcomes Gail Marcus, MD, MBA, as an Expert in Residence (EIR). With extensive senior leadership experience in healthcare and biotech, she has led both Fortune 100 companies, including Cigna Healthcare and UnitedHealthcare, and venture-backed startups. Gail was named one of Massachusetts' top 100 women leaders during her tenure as CEO of a diagnostic venture. She has successfully launched and scaled early-stage companies in both the US and UK across various sectors, including managed care, pharmacy benefit management, diagnostics, and healthcare services. Michele Colucci, Esq., DigitalDx Ventures Founder + Managing Partner said, “We are so incredibly honored to have Gail join our DigitalDx EIR brain trust! I have known Gail for many years and her knowledge, integrity and warmth are unparalleled. We are very excited to add her insights to our family of experts focused on finding the best tests to save lives earlier, faster, more accurately and less invasively... an inspired vision we all share. Currently, Gail serves on several public and private boards, including Natera (NTRA, Nasdaq), where she is a board member, and biomodal, a UK-based DNA sequencing company, where she serves as Board Chair. Gail’s experience spans governance committees, including Audit, Compensation, Risk Management, and Nominating & Governance (Chair). She also advises startups through Martin Trust Center for MIT Entrepreneurship and holds certifications in cybersecurity and financial expertise. Gail holds a BA Summa Cum Laude from Wesleyan University, an MBA from The Wharton School, a Master’s in Computer Science from the University of Pennsylvania, and a Doctor of Health Administration from the Medical University of South Carolina. Welcome Dr. Gail Marcus! DigitalDx Ventures is a majority women-owned impact fund focused on delivering a triple bottom line: meaningful returns, access to healthcare, and gender parity. #venturecapitalnews #ventureinvesting #impactinvesting #biotechnews

DigitalDx Ventures Founder + Managing Partner Michele Colucci, Esq. joined an esteemed group of health tech leaders for an incredible evening at White & Case LLP in Manhattan for a panel on “Activating Women in Shaping the Future of Women’s Health.” The event was sponsored by Georgetown University’s #HoyasinHealth and Columbia University’s Global Health and Wellness Network. PANELISTS: ⭐ Michele Colucci, Esq. — Founder + Managing Partner DigitalDx Ventures ⭐ Jacqueline Giannelli RN, MSN, FNP-BC, NCMP — Midlife and Menopause expert ⭐ Suzanne Schmidt MSc — Client Success Director Included Health ⭐ Hope Yates, JD, MPH — Chief Strategy Officer Women's Health Columbia University Irving Medical Center ⭐ And moderator, Delphine O'Rourke, JD Special thanks to Bethany Hills Grois, JD/MPH for hosting the event at White & Case LLP. #ImpactInvesting #WomensHealth #AIinHealthcare #HealthEquity #HealthTechNews

It’s been a big week for DigitalDx Ventures at the Life Science Intelligence (LSI) Emerging MedTech Conference in Dana Point. On Tuesday morning (March 18) Optina Diagnostics CEO Dave Anderson addressed the conference and discussed Optina’s game-changing FDA 510(k) cleared hyper spectral camera and AI platform to enable eye specialists to more accurately diagnose and manage early, intermediate and late-stage retinal disease, including monitoring therapeutic effectiveness in at-risk patients. Tomorrow morning (March 20) at 11:25AM (PDT) NOWDiagnostics | NOWDx CEO Robert Weigle will discuss the “Touch to Test” over-the-counter and point of care diagnostic tests that yield results in minutes developed and manufactured by NOWDx. Last August NOWDx was granted marketing authorization by the FDA for their 'First to Know Syphilis Test.' The company’s patented approach allows for virtually any immunological assay to be accurately performed onsite in one step using a tiny amount of capillary blood or, in some cases, saliva. In addition, two of DigitalDx Ventures' Experts-in-Residence were featured at LSI. Laura Yecies CEO of Osteoboost Health, Inc. presented on stage and Debbie Lin, PhD PhD participated in a panel titled "How Can Clinical, Supplier, and Other Types of Partnerships Make Precision Medicine a Reality?" . #AI #HealthTech #HealthTechNews #ImpactInvesting #EarlyDiagnostics

CALLING ALL WOMEN ENTREPRENEURS: 🔊 The WE Empower UN SDG Challenge is live! This 🌎 global challenge for business leaders and #changemakers will bring together five awardees from around the world for UN Global Goals week to take part in tailored trainings, networking, the opportunity to pitch their businesses for a grant and much MORE. Learn more and apply TODAY! https://lnkd.in/euW87T5 Amanda Ellis Pauline Koelbl Lina Maria Useche Jaramillo Edda Aradottir Tatiana Estevez Teresa Njoroge WE Empower UN SDG Challenge #Goal5 #ShEquity #WEEmpower #ImpactInvesting #GenderLens Michele Colucci, Esq. Erin Niehaus - CFP®, CEPA

Two of DigitalDx Ventures’ portfolio company CEOs will be presenting at this week’s Life Science Intelligence (LSI) Emerging Medtech Summit in Southern California. On Tuesday morning (March 18) Optina Diagnostics CEO Dave Anderson will address the conference and discuss Optina’s game-changing FDA 510(k) cleared hyper spectral camera and AI platform to enable eye specialists to more accurately diagnose and manage early, intermediate and late-stage retinal disease, including monitoring therapeutic effectiveness in at-risk patients. On Thursday morning (March 20) NOWDiagnostics | NOWDx CEO Robert Weigle will discuss the “Touch to Test” over-the-counter and point of care diagnostic tests that yield results in minutes developed and manufactured by NOWDiagnostics | NOWDx. The company’s patented approach allows for virtually any immunological assay to be accurately performed onsite in one step using a tiny amount of capillary blood or, in some cases, saliva. In addition two of DigitalDx Ventures Experts in Residence Laura Yecies and Debbie Lin, PhD will also present onstage at LSI. #AI #HealthTech #HealthTechNews #ImpactInvesting #EarlyDiagnostics

DigitalDx Ventures Founder + Managing Partner Michele Colucci, Esq. will be featured on a dynamic panel next week in New York titled "Activating Women in Shaping the Future of Women's Health." The panel is sponsored by Georgetown University's Hoyas in Health and Columbia University's Global Health and Wellness Network. The event is hosted by Bethany Hills Grois, JD/MPH Partner at White & Case LLP, in Manhattan. 🗓️ Tuesday, March 18, 2025 ⏰ 6:30 PM (EASTERN) Featured Speakers: ⭐ Michele Colucci, Esq. — Founder + Managing Partner DigitalDx Ventures ⭐ Jacqueline Giannelli RN, MSN, FNP-BC, NCMP — Midlife and Menopause expert ⭐ Suzanne Schmidt, MSc — Client Success Director Included Health ⭐ Amy West — Principal HITLAB Advisory Services ⭐ Hope Yates, JD, MPH — Chief Strategy Officer Women's Health Columbia University Irving Medical Center ⭐ Moderator: Delphine O'Rourke, JD #LeadersInHealth #HealthTech #ImpactInvesting #WomenInHealth #HealthTechNews

In honor of International Women's Day, all of us at DigitalDx Ventures would like to express gratitude for the extraordinary leaders on our team that make the ground-breaking work we do in health diagnostics possible. Michele Colucci, Esq., JD — Founder and Managing Partner Erin Niehaus - CFP®, CEPA, MBA  Vanessa Small PhD, MBA   Anula Jayasuriya, MD, MBA, PHD Melody Po, MBA Maureen Downey, MBA Jennifer Quigley Debbie Lin, PhD Mrunalini Parvataneni, MD Maria T. Millan, MD Alissa Hsu Lynch, MBA L. Jasmine Kim, MBA Elise Singer MD MBA, MD, MBA Hoda Asmar, MD, MBA, Tracy George, MD Jean Machart, MBA Molly Martell Renee Ryan, MBA Valerie Kozak Rumi Yokota, FPN, MBA Amit Goldman Golman, MBA Anita Samarth Laura Mezey, JD Laura Yecies MBA Carolyn Miller McCusker Stefanie Lingle Beasley #InternationalWomensDay #WomeninVenture #VentureCapital #VC #ImpactInvesting